NAUT News and Press, Nautilus Biotechnology Inc. From 10/31/23

SEATTLE, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule proteome analysis platform, today reported financial results for the third quarter ended September 30, 2023. “I’m ve...

Tennant Company (TNC) is expected to report for Q3 2023 Stellantis N.V. (STLA) is expected to report for Q3 2023 Marathon Petroleum Corporation (MPC) is expected to report $7.79 for Q3 2023 Easterly Government Properties Inc. (DEA) is expected to report $0.29 for Q3 2023 Allegion ...

Nautilus Biotechnology Inc. (NAUT) is expected to report $-0.18 for Q3 2023

2023-10-23 07:23:28 ET Summary Nautilus Biotechnology is developing a molecule protein fingerprinting system with applications in pharmaceutical development and diagnostics. They have important patents. The potential market size for Nautilus is conservatively estimated to be aroun...

SEATTLE, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced it will report financial results for the third quarter before market open on Tuesday, October 31, ...

2023-09-28 17:12:16 ET Gainers: Editas Medicine ( NASDAQ: EDIT ) +8% . Marqeta ( MQ ) +3% . Cipher Mining ( CIFR ) +3% . Aclaris Therapeutics ( ACRS ) +2% . Biora Therapeutics ( BIOR ) +2% . Losers: Jaguar Global Grow...

SEATTLE, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating in the following investor conferences: Morgan Stanley 2...

SEATTLE, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating in the following investor conferences: Canaccord 43 rd...

2023-08-02 13:33:02 ET Nautilus Biotechnology, Inc. (NAUT) Q2 2023 Earnings Conference Call August 02, 2023 08:30 AM ET Company Participants Carrie Mendivil - Investor Relations Sujal Patel - Co-Founder, Chief Executive Officer, President, Secretary & Director ...

2023-08-02 07:49:27 ET Nautilus Biotechnology press release ( NASDAQ: NAUT ): Q2 GAAP EPS of -$0.13 beats by $0.01 . Cash, cash equivalents, and investments were $286.7 million as of June 30, 2023. For further details see: Nautilus Biotechnology GAAP EPS...